IQVIA™ Real-World Insights Bibliography

Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018
Author(s): Magali Lemaitre 1, Fayssoil Fouad 1, Fabrice Carrat 2 3, Pascal Crépey 4, Jacques Gaillat 5, Gaëtan Gavazzi 6, Odile Launay 7 8, Anne Mosnier 9, Marie-Cécile Levant 10, Mathieu Uhart 10
Affiliations(s): 1 IQVIA, Courbevoie, France. 2 Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (Inserm), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. 3 Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France. 4 Université de Rennes, EHESP, REPERES-EA 7449, Rennes, France. 5 Centre Hospitalier Annecy-Genevois, Metz-Tessy, France. 6 CHU Grenoble Alpes, Clinique Universitaire de Gériatrie, Pavillon Elisée-Chatin, and GREPI EA 7408, Université Grenoble Alpes, Grenoble, France. 7 Faculté de Médecine Paris Descartes, Université de Paris, Paris, France. 8 Inserm, CIC 1417, F-CRIN I-REIVAC, Assistance Publique-Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France. 9 Open Rome & Réseau des GROG, Paris, France. 10 Sanofi Pasteur, Lyon, France.
Publication(s):  Influenza Other Respir Viruses . 2022 Jan 10. doi: 10.1111/irv.12962.
Document Type(s): Abstract,
Countries: France,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2022
  L:
A:
English
Methodology, Population Based Study,
  Add to report
 
 
Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
Author(s): Kjell Larsson,1 Karin Lisspers,2 Björn Ställberg,2 Gunnar Johansson,2 Florian S Gutzwiller,3 Karen Mezzi,3 Bine Kjoeller Bjerregaard,4 Leif Jorgensen,4 Hyewon Koo,5 Christer Janson6
Affiliations(s): 1Integrative Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 2Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden; 3Novartis Pharma AG, Basel, Switzerland; 4IQVIA Solutions, Copenhagen, Denmark; 5IQVIA Solutions, Solna, Sweden; 6Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden
Publication(s):  International Journal of Chronic Obstructive Pulmonary Disease 2022:17 1409?1421 https://doi.org/10.2147/COPD.S364932
PMID 35761954
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2022
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Population Based Study, Real World Data, Retrospective cohort analysis,
  Add to report
 
 
Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database
Author(s): C. Hopkins - S. Conlon - S. Chavda - R. Hudson - R. Rout
Affiliations(s): Guy's and St. Thomas' Hospital, Kings college, London, UK. Sanofi Genzyme UK, Reading, UK. IQVIA, London, UK.
Publication(s):  Rhinology 60-4: 252-260, 2022
Document Type(s): Article,
Countries: England,
Click here for the abstract
C:
Y:
Respiratory disease, Surgery,
2022
  L:
A:
English
Budget impact, Burden of illness, Cost analysis, Retrospective database analysis,
  Add to report
 
 
Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension
Author(s): Allan Lawrie1,2|Neil Hamilton3|Steven Wood2,4|Fernando Exposto5|Ruvimbo Muzwidzwa5|Louise Raiteri5|Amélie Beaudet6|Audrey Muller6|Rafael Sauter6|Nadia Pillai6|David G. Kiel
Affiliations(s): 1National Heart and Lung Institute,Imperial College London, London, UK2Insigneo Institute for In?Silico Medicine,University of Sheffield, Sheffield, UK3Sheffield Pulmonary Vascular DiseaseUnit, Sheffield Teaching Hospitals NHSFoundation Trust, Royal HallamshireHospital, Sheffield, UK4Scientific Computing, Sheffield TeachingHospitals NHS Foundation Trust, RoyalHallamshire Hospital, Sheffield, UK5IQVIA, London, UK6Actelion Pharmaceuticals Ltd.,Allschwil, Switzerland7Department of Infection, Immunity andCardiovascular Disease, University ofSheffield, Sheffield, UK
Publication(s):  Pulmonary Circulation. 2022;12:e12136.wileyonlinelibrary.com/journal/pul2|1of10https://doi.org/10.1002/pul2.12136
Document Type(s): Article,
Countries: Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Respiratory disease,
2022
  L:
A:
English
Observational study, Retrospective cohort analysis,
  Add to report
 
 
Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Author(s): Naoya Ueda 1, Anzu Yakushiji 2, Jonathan Schelfhout 3, Shigeru Tokita 1, Takekazu Kubo 4* (rwesheorj 2)
Affiliations(s): 1) Medical Affairs, MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Merck & Co Inc, Rahway, NJ, USA 4) Medical Affairs, MSD K.K., Tokyo, Japan
Publication(s):  BMC Pulmonary Medicine
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Respiratory disease,
2022
  L:
A:
English
Burden of illness, Patient questionnaire,
  Add to report
 
 
Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Author(s): Naoya Ueda 1, Anzu Yakushiji 2, Jonathan Schelfhout 3, Shigeru Tokita 1, Takekazu Kubo 1* (rwesheorj 2)
Affiliations(s): 1) MSD Co., Ltd., Medical Affairs 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Merck & Co Inc, Kenilworth, New Jersey, USA
Publication(s):  The 62nd Annual Meeting of the Japanese Respiratory Society
Document Type(s): Conference, Poster, Presentation,
Countries: Japan,
Click here for the abstract
C:
Y:
Respiratory disease,
2022
  L:
A:
Japanese
Patient questionnaire,
  Add to report
 
 
Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain
Author(s): Ángel Gil-de-Miguel 1, Federico Martinón-Torres 2 3 4, Javier Díez-Domingo 5, Raúl Ortiz de Lejarazu Leonardo 6, Tomàs Pumarola 7, Mafalda Carmo 8, Georgina Drago 9, Juan Luis López-Belmonte 9, Hélène Bricout 10, Caroline de Courville 10, Esther Redondo Margüello 11
Affiliations(s): 1Public Health and Medical Specialties Department, Health Sciences Faculty, Juan Carlos University, Madrid, Spain. angel.gil@urjc.es. 2Genetics, Vaccines and Paediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain. 3Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. 4Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela (USC), Galicia, Spain. 5Vaccine Research Department, FISABIO, Valencia, Spain. 6National Influenza Centre, Hospital Clínico Universitario, Universidad de Valladolid, Valladolid, Spain. 7Virology Section, Department of Microbiology, Barcelona Centre for International Health Research (CRESIB, Hospital Clínic - Universitat de Barcelona), Barcelona, Spain. 8IQVIA, Barcelona, Spain. 9Sanofi, Barcelona, Spain. 10Sanofi, Lyon, France. 11International Health Centre Madrid Health, City Council of Madrid, Madrid, Spain.
Publication(s): 
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2022
  L:
A:
English
Burden of illness,
  Add to report
 
 
Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study
Author(s): F Martinón-Torres 1 2 3, M Carmo 4, L Platero 5, G Drago 6, J L López-Belmonte 6, M Bangert 7, J Díez-Domingo 8, M Garcés-Sánchez 9
Affiliations(s): 1Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, Galicia, Spain. Federico.Martinon.Torres@sergas.es. 2Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Rúa da Choupana, s/n, Santiago de Compostela, Galicia, 15706, A Coruña, Spain. Federico.Martinon.Torres@sergas.es. 3CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Federico.Martinon.Torres@sergas.es. 4IQVIA, Barcelona, Spain. 5Sanofi, Madrid, Spain. 6Sanofi, Barcelona, Spain. 7Sanofi, Lyon, France. 8Vaccine Research Department, FISABIO, Valencia, Spain. 9Pediatrics Service, Nazaret Health Center, Valencia, Spain.
Publication(s):  BMC Infect Dis . 2022 Sep 29;22(1):759. doi: 10.1186/s12879-022-07745-0.
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2022
  L:
A:
English
Burden of illness,
  Add to report
 
 
Excess hospitalizations and mortality associated with seasonal influenza in Portugal, 2008?2018
Author(s): Filipe Froes 1, Mafalda Carmo 2, Hugo Lopes 3 4 5, Geoffray Bizouard 6, Catarina Gomes 7, Margarida Martins 7, Hélène Bricout 8, Caroline de Courville 8, Jaime Correia de Sousa 9 10, Carlos Rabaçal 11, João F Raposo 12, Carlos Robalo Cordeiro 13
Affiliations(s): 1ICU, Thorax Department, Centro Hospitalar Universitário Lisboa Norte, Av. Prof. Egas Moniz MB, 1649-028, Lisbon, Portugal. filipe.froes@gmail.com. 2IQVIA, Barcelona, Spain. 3IQVIA, Lisbon, Portugal. 4NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal. 5Comprehensive Health Research Center (CHRC)-Universidade NOVA de Lisboa, Lisbon, Portugal. 6IQVIA, Paris, France. 7Sanofi, Lisbon, Portugal. 8Sanofi, Lyon, France. 9Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 10ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal. 11Vila Franca de Xira Hospital, Lisbon, Portugal. 12APDP and NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal. 13Pulmonology Department, Coimbra University Hospital, University of Coimbra, Coimbra, Portugal.
Publication(s):  BMC Infect Dis . 2022 Sep 7;22(1):726. doi: 10.1186/s12879-022-07713-8.
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2022
  L:
A:
English
Burden of illness,
  Add to report
 
 
Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning ? Based on the ARCTIC Study
Author(s): Björn Ställberg 1, Karin Lisspers 1, Kjell Larsson 2, Christer Janson 3, Mario Müller 4, Mateusz Łuczko 5, Bine Kjøller Bjerregaard 6, Gerald Bacher 7, Björn Holzhauer 7, Pankaj Goyal 7, Gunnar Johansson 1
Affiliations(s): 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden. 3Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 4Department of Data Science and Advanced Analytics, IQVIA, Frankfurt Am Main, Germany. 5Department of Data Science and Advanced Analytics, IQVIA, Warsaw, Poland. 6Department of Real World Evidence Solutions, IQVIA, Copenhagen, Denmark. 7Department of Clinical Development and Analytics, Novartis Pharma AG, Basel, Switzerland.
Publication(s):  Journal: Int J Chron Obstruct Pulmon Dis. 2021 Mar 16;16:677-688. doi: 10.2147/COPD.S293099. eCollection 2021. Conference: IPCRG, Dublin, Ireland, Weekly series of Clinical Practice Webinars - Various Saturdays from 16th May to 27th June 2020
PMID: 33758504 PMCID: PMC7981164 DOI: 10.2147/COPD.S293099
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Epidemiological study, Population Based Study,
  Add to report
 
 
First Page Previous Page  2 of 29 Next Page Last Page